AstraZeneca Plc (AZN) raised its forecast after reporting quarterly profit that beat analyst estimates, helped by a $200 million payment from one-time suitor Pfizer Inc. for rights to a version of the Nexium heartburn treatment.
Showing posts with label Pfizer. Show all posts
Showing posts with label Pfizer. Show all posts
May 03, 2014
AstraZeneca rejects Pfizer's $106 billion bid
AstraZeneca has rejected Pfizer's sweetened takeover bid, describing the proposed $106 billion deal as inadequate.
Subscribe to:
Posts (Atom)